Jennifer P. Rubin, MD

Clinical and Community Trials

Biography

  • Attending Physician, Neurology, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Neurology and Epilepsy), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Neurology, Children's Memorial Hospital 2005-2008
  • Residency in Pediatrics, Children's Memorial Hospital 2002-2005
  • MD, University of Louisville School of Medicine 2002

Clinical Studies

Recruiting

A Study of AAV9 Gene Therapy in Children with Canavan Disease (CANaspire Clinical Trial)

Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease

Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis

Publications

May. 10, 2022

Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease.

Jan. 18, 2022

Association Between Time Spent Outdoors and Risk of Multiple Sclerosis.

Apr. 03, 2021

Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease.

See all publications

Similar Researchers

Reega D. Purohit, MD

Natalia Henner, MD

Recent Publication

Navigating the post-Dobbs landscape: ethical considerations from a perinatal perspective.

Jan. 29, 2024

Joshua L. Goldstein, MD

Research Interests

Neurocritical Care, Epilepsy, Seizures

Recent Publication

Pediatric status epilepticus management by Emergency Medical Services (the pSERG cohort).

Jul. 16, 2023

Joanna S. Blackburn, MD

Recent Publication

A GNAI1 Pathogenic Variant in a Case with GNAO1-Isolated Dystonia: A Modifier of Disease Severity?

Feb. 28, 2024
Clinical and Community Trials

Kendra M. Ward, MD, MSCI

Recent Publication

The Child Opportunity Index 2.0 and Disparities in Pediatric Cardiorespiratory Fitness.

Feb. 17, 2024
Clinical and Community Trials

Joyce Wu, MD

Recent Publication

Common epilepsy variants from the general population are not associated with epilepsy among individuals with tuberous sclerosis complex.

Feb. 17, 2024